Article: Nicotinamide Riboside Supplementation in Mild Cognitive Impairment: Clinical Findings

Clinical Mild Cognitive Impairment Neurological Health

Nicotinamide Riboside Supplementation in Mild Cognitive Impairment: Clinical Findings

Objectives

To determine the safety of oral NR supplementation in older adults with mild cognitive impariment (MCI), and investigate its effects on cognition, brain volume and functioning, and physical function.

Journal

GeroScience

Key Outcomes

Cognitive function measures remained stable in both NR and placebo groups throughout the study.
Global methylation analyses trended towards a modest NR-associated increase in DNA methylation.

Duration

10 weeks

Dose

1000 mg

Study Design

Randomized, double-blind, placebo-controlled, phase II, pilot study in 20 primarily Hispanic older adults with mild cognitive impairment (MCI)

See Published Study

Autoimmune Disease

Nicotinamide Riboside Supplementation Reduces Inflammatory Markers in Immune Cells from Healthy Subjects and Psoriasis Patients: Clinical Findings

Objectives To examine how ex-vivo NR supplementation affects adaptive immunity in CD4+ T cells extracted from healthy subjects and those with mild-moderate psoriasis, and to investigate the in viv...

Clinical

Nicotinamide Riboside Supplementation Increases Brain NAD+ Levels in Humans: Clinical Findings

Objectives To investigate the effects of acute NR supplementation on cerebral NAD+ levels in the healthy human brain using a specialized MRI technique called downfield proton magnetic resonance sp...